Dear User,
On May 25, 2018, Regulation (EU) 2016/679 of the European Parliament and of the Council of April 27, 2016 (General Data Protection Regulation) came into force. We encourage you to familiarise yourself with information about the processing of personal data on the PolskieRadio.pl website.
1.The Data Administrator is Polish Radio S.A., based at 77/85 Niepodległości Ave., 00-977, Warsaw.
2.On issues regarding your data, please contact the Data Protection Officer, e-mail: iod@polskieradio.pl, tel. 22 645 34 03.
3.Personal data may be processed for marketing purposes based on consent.
4.Personal data may be shared solely for the purpose of proper implementation of services defined in the privacy policy.
5.Personal data will not be transferred outside the European Economic Area or to an international organisation.
6.Personal data will be stored for 5 years after an account is deactivated, in accordance with the law.
7.You have the right to access your personal data, correct it, to have it moved or deleted, or to limit its processing.
8.You have the right to object to further processing, and in the case of voicing consent to the processing of personal data, you have the right to withdraw your consent. The exercise of the right to withdraw consent does not affect any processing that has already taken place.
9.You have the right to lodge a complaint with the supervisory authority.
10.Polish Radio S.A. declares that no automated decisions are made when personal data is processed, and that profiling is not used.
For more information on this subject, please read our personal data and privacy policy.
English Section

EU agrees to buy 300 million doses of COVID-19 vaccine from Pfizer/BioNTech

12.11.2020 15:00
The European Union has struck a deal to buy up to 300 million doses of a potential coronavirus vaccine from US pharmaceutical firm Pfizer and its German partner BioNTech.
  • Poland to get COVID-19 vaccine in spring: audio report

Deliveries are expected to start by the end of this year, assuming the vaccine is cleared by regulators and approved for general use.

The deal comes after Pfizer and BioNTech announced on Monday that their experimental COVID-19 vaccine was more than 90 percent effective based on initial trial results.

"In the wake of Monday's promising announcement by BioNTech and Pfizer on the prospects for their vaccine, I'm very happy to announce today's agreement ... to purchase 300 million doses," European Commission President Ursula von der Leyen said in a statement on Wednesday.

European Health Commissioner Stella Kyriakides was quoted as saying that the vaccine deal followed "the encouraging first indications from the clinical trial results" and was "a very telling example of what the EU can achieve when working together, as a Union."

Kyriakides tweeted on Thursday that "a safe and effective COVID-19 vaccine will not return us to normality overnight, but will play a major role in saving lives and livelihoods, restoring our economy and protecting our healthcare systems."

Poland’s Prime Minister Mateusz Morawiecki said on Monday that millions of vaccines against the coronavirus were likely to reach his country next spring as part of a European deal with drug makers.

He added that the vaccine would be made available to citizens on an optional basis and be first administered to senior citizens, healthcare professionals and law enforcement personnel.

Morawiecki also said that he had issued instructions for an infrastructure to be put in place next year for nationwide vaccinations against COVID-19.

The Polish prime minister said in a social media post on Thursday that Poles would be able to access the vaccine "as soon as it's ready."

Poland on Thursday reported 22,683 new coronavirus infections and 275 more deaths, bringing its total number of cases to 641,496 and fatalities to 9,080.


Source: PAPec.europa.eu

Click on the audio player above for a report by Radio Poland's Sławek Szefs.